Comment diagnostiquer une dysfonction gonadique ?

Un diagnostic se fait par des tests hormonaux et des examens d'imagerie.

Quels examens pour évaluer la santé des gonades ?

Des analyses sanguines et des échographies peuvent être réalisées.

Quels signes indiquent une anomalie des gonades ?

Des irrégularités menstruelles ou des problèmes de fertilité peuvent indiquer une anomalie.

Comment détecter un cancer des gonades ?

Des examens d'imagerie et des marqueurs tumoraux sont utilisés pour le dépistage.

Quel rôle joue l'échographie dans le diagnostic ?

L'échographie permet de visualiser les structures gonadiques et détecter des anomalies.

Quels symptômes d'une insuffisance gonadique ?

Fatigue, troubles de la libido et irrégularités menstruelles sont fréquents.

Comment reconnaître un déséquilibre hormonal ?

Des changements d'humeur, de poids et de libido peuvent signaler un déséquilibre.

Quels signes d'inflammation des gonades ?

Douleurs abdominales, fièvre et gonflement peuvent indiquer une inflammation.

Quels symptômes d'un cancer des gonades ?

Des masses palpables, douleurs et changements dans les habitudes urinaires peuvent survenir.

Quels symptômes d'une hyperplasie gonadique ?

Des menstruations irrégulières et des signes de virilisation peuvent être présents.

Comment prévenir les maladies gonadiques ?

Un mode de vie sain, une alimentation équilibrée et des examens réguliers aident.

Quel rôle des vaccinations dans la prévention ?

Certaines vaccinations, comme contre le HPV, peuvent prévenir des cancers gonadiques.

Comment éviter les infections gonadiques ?

Pratiquer des rapports protégés et éviter les partenaires multiples réduit le risque.

Quels examens réguliers pour la santé gonadique ?

Des bilans hormonaux et des échographies peuvent être recommandés selon l'âge.

Comment réduire le risque de cancer des gonades ?

Éviter le tabac, maintenir un poids santé et se faire dépister régulièrement.

Quels traitements pour l'insuffisance gonadique ?

Des thérapies hormonales substitutives sont souvent prescrites.

Comment traiter un cancer des gonades ?

Chirurgie, chimiothérapie et radiothérapie sont des options de traitement.

Quelles options pour la dysfonction érectile ?

Des médicaments, des dispositifs ou des thérapies hormonales peuvent être utilisés.

Comment gérer une hyperplasie gonadique ?

Des médicaments hormonaux et parfois une intervention chirurgicale sont nécessaires.

Quels traitements pour les infections gonadiques ?

Des antibiotiques ou antiviraux sont prescrits selon l'infection.

Quelles complications d'une insuffisance gonadique ?

Elle peut entraîner des problèmes de fertilité et des troubles osseux.

Quels risques liés à un cancer des gonades ?

Des métastases et des complications liées aux traitements peuvent survenir.

Quelles complications d'une hyperplasie gonadique ?

Elle peut causer des troubles menstruels et un risque accru de cancer.

Quels effets secondaires des traitements hormonaux ?

Des changements d'humeur, des nausées et des risques thromboemboliques peuvent se produire.

Quelles complications des infections gonadiques ?

Elles peuvent entraîner des douleurs chroniques et des problèmes de fertilité.

Quels facteurs de risque pour le cancer des gonades ?

Antécédents familiaux, âge avancé et exposition à des substances cancérigènes augmentent le risque.

Comment le mode de vie influence-t-il la santé gonadique ?

Le tabagisme, l'obésité et le stress peuvent affecter la fonction gonadique.

Quels médicaments peuvent affecter les gonades ?

Certains stéroïdes et médicaments anticancéreux peuvent altérer la fonction gonadique.

Quel impact des infections sur la santé gonadique ?

Les infections sexuellement transmissibles peuvent endommager les gonades et affecter la fertilité.

Quels facteurs environnementaux influencent les gonades ?

L'exposition à des produits chimiques et à des radiations peut nuire à la santé gonadique.

Gonades - Informations médicales vérifiées

Pharmacokinetics and tolerability of intranasal or intravenous administration of nalbuphine in infants.

01 2023

DOI: 10.1136/archdischild-2022-323807 PMID: 36100355

Intranasal nalbuphine could be a safe, efficacious and non-invasive alternative to parenteral pain medication in infants. We aimed to assess pharmacokinetics (PK) and tolerability of intranasal and in... Prospective open-label study including infants 1-3 months of age admitted to the emergency department, receiving nalbuphine for procedural pain management. Patients were alternately allocated to a sin... Out of 52 study subjects receiving nalbuphine, 31 were eligible for NCA (11 intravenous, 20 intranasal). Median AUC... This is the first study investigating intranasal administration of nalbuphine in infants suggesting an intranasal bioavailability close to 50%. Non-invasive intranasal application was well tolerated. ... NCT03059511....

Humans Infant Administration, Intranasal Administration, Intravenous Biological Availability +3 autres

A case of intravenous iron administration resulting in cerebral edema expansion.

30 May 2023

DOI: 10.1186/s12883-023-03258-8 PMID: 37254070

Iron plays an important role in the development of perihematomal edema (PHE) in the setting of intracerebral hemorrhage (ICH). Cerebral iron is increased via direct hemoglobin release in ICH, and seve... A 46-year-old woman was admitted to the hospital with acute moderate-to-severe TBI. Her head computed tomography (CT) scan showed bifrontal hemorrhagic contusions with mild PHE. She was started on hyp... We believe this is the first report of exacerbating PHE accompanied by clinical decline after intravenous iron administration in the setting of acute hemorrhagic brain contusions. Though the effects o...

Humans Female Middle Aged Brain Edema Iron +5 autres

Feasibility of periprocedural decision on the administration of intravenous contrast media in MRI for endometriosis.

Aug 2023

DOI: 10.1016/j.ejrad.2023.110949 PMID: 37392544

To assess the feasibility of a periprocedural decision on the administration of intravenous contrast media in MRI for endometriosis and to evaluate the frequency and reasons of contrast administration... In this retrospective, descriptive cross-sectional single-center study all patients were included, who received a pelvic MRI for evaluation of endometriosis between April 2021 and February 2023. Frequ... 303 consecutive patients (mean age, 33.4 years +/- 8.3 [standard deviation]) were evaluated. Periprocedural decision on the administration of intravenous contrast media had been made in all cases. For... A periprocedural decision on the administration of contrast media in MRI for endometriosis is feasible with little effort. It allows the administration of contrast media to be avoided in most cases. I...

Female Humans Adult Endometriosis Contrast Media +6 autres

Optimization of intravenous administration of hydroxocobalamin in pediatric emergencies - HYDROX-OPTIMIS study.

Nov 2023

DOI: 10.1016/j.ienj.2023.101353 PMID: 37871551

Procedures to prepare and infuse intravenous drugs are poorly documented.... To determinate the optimal mode of hydroxocobalamin administration in children in emergency care.... We identified three modes of administration: (1) connect infusion tubing to the vial, start the infusion and interrupt it when the desired dose has been delivered; (2) remove from the vial the volume ... 25 nurses performed each of these three procedures for children weighting 15 and 30 kg. Speed and precision were primary end-points; ease, safety and drug economy were secondary end-points.... Mode 3 was the fastest (42[37-61] sec) followed by modes 1 and 2 (p < 0.05). Mode 3 was the most precise (100[100-100]%) followed by modes 1 and 2 (p = 0.001). Mode 3 was the easiest (10.0[9.0-10.0]) ... Taking the required volume from the vial and infuse directly was the fastest, the most precise, the easiest and most economical mode of administration. It should be recommended....

Child Humans Hydroxocobalamin Emergencies Infusions, Intravenous +1 autres

Clinical Administration Characteristics of Subcutaneous and Intravenous Administration of Daratumumab in Patients With Multiple Myeloma at Mayo Clinic Infusion Centers.

04 2023

DOI: 10.1200/OP.22.00421 PMID: 36758192

Median duration of daratumumab (DARA) administration for treatment of multiple myeloma is 3-7 hours for the intravenous formulation (DARA IV) and 3-5 minutes for the subcutaneous formulation (DARA SC)... Time-based measurements were extracted using a scheduling/pharmacy software program that tracked patient movement through appointments for patients initiating DARA in Mayo Clinic infusion centers from... Median total clinic times were 2.7-3.0 hours shorter for DARA SC versus DARA IV. Median clinic times were highest at dose 1 and decreased with subsequent doses. Median total chair times were 2.7-2.8 h... Reduced clinic times were observed with DARA SC, indicating that use of DARA SC as a treatment option results in time savings that may free clinic resources. Furthermore, novel methods of electronic h...

Humans Multiple Myeloma Antibodies, Monoclonal Infusions, Intravenous Administration, Intravenous

Intravenous Opioid Administration During Mechanical Ventilation and Use After Hospital Discharge.

03 Jun 2024

DOI: 10.1001/jamanetworkopen.2024.17292 PMID: 38874921

Guidelines recommend an analgesia-first strategy for sedation during mechanical ventilation, but associations between opioids provided during mechanical ventilation and posthospitalization opioid-rela... To evaluate associations between an intravenous opioid dose received during mechanical ventilation and postdischarge opioid-related outcomes in medical (nonsurgical) patients.... This retrospective cohort study evaluated adults receiving mechanical ventilation lasting 24 hours or more for acute respiratory failure and surviving hospitalization. Participants from 21 Kaiser Perm... Terciles of median daily intravenous fentanyl equivalents during mechanical ventilation.... The primary outcome was the first filled opioid prescription in 1 year after discharge. Secondary outcomes included persistent opioid use and opioid-associated complications. Secondary analyses tested... The study included 6746 patients across 21 hospitals (median age, 67 years [IQR, 57-76 years]; 53.0% male). Of the participants, 3114 (46.2%) filled an opioid prescription in the year prior to admissi... In this retrospective cohort study of patients receiving mechanical ventilation, opioids administered during mechanical ventilation were associated with opioid prescriptions following hospital dischar...

Humans Male Female Analgesics, Opioid Respiration, Artificial +7 autres

The Relationship between Rate and Volume of Intravenous Fluid Administration and Kidney Outcomes after Angiography.

10 2022

DOI: 10.2215/CJN.02160222 PMID: 36008352

Contrast-associated AKI may result in higher morbidity and mortality. Intravenous fluid administration remains the mainstay for prevention. There is a lack of consensus on the optimal administration s... We conducted a secondary analysis of 4671 PRESERVE participants who underwent angiographic procedures. Although fluid type was randomized, strategy of administration was at the discretion of the clini... The mean (SD) age was 70 (8) years, 94% of participants were male, and median (interquartile range) eGFR was 60 (41-60) ml/min per 1.73 m... We found that administration of a total volume of 1000 ml, starting at least 1 hour before contrast injection and continuing postcontrast for a total of 6 hours, is associated with a similar risk of a...

Aged Female Humans Male Acute Kidney Injury +5 autres

The Metabolism of Lufotrelvir, a Prodrug Investigated for the Treatment of SARS-COV2 in Humans Following Intravenous Administration.

10 2023

DOI: 10.1124/dmd.123.001416 PMID: 37429728

The metabolism of lufotrelvir, a novel phosphate prodrug of PF-00835231 for the treatment of COVID-19, was evaluated in healthy human volunteers and clinical trial participants with COVID-19 following...

Humans Carbon Radioisotopes Infusions, Intravenous Prodrugs RNA, Viral +6 autres

Pharmacokinetics and Safety of Vedolizumab Following Administration of a Single Intravenous Dose in Healthy Chinese Subjects.

Jan 2023

DOI: 10.1007/s13318-022-00804-6 PMID: 36400983

Vedolizumab is a humanized monoclonal antibody, indicated for the treatment of moderately to severely active ulcerative colitis (UC) or Crohn's disease (CD), that specifically binds to the α4β7 integr... Sixteen participants received a single IV infusion of vedolizumab (300 mg). Blood samples were collected to measure vedolizumab serum concentrations. The safety of all subjects was monitored.... The pharmacokinetic analysis showed that vedolizumab reached the maximum observed serum concentration (C... Vedolizumab was well tolerated in healthy Chinese subjects when administered as a single-dose IV 300 mg infusion. In this study, the rate of AVA positivity was 37.5%, which occurred near the end of th... http://www.chinadrugtrials.org.cn : CTR20171528....

Adult Humans East Asian People Colitis, Ulcerative Administration, Intravenous +2 autres

Epinephrine administration in adults with out-of-hospital cardiac arrest: A comparison between intraosseous and intravenous route.

05 2023

DOI: 10.1016/j.ajem.2023.02.003 PMID: 36806977

The benefits and risks of the intraosseous (IO) route for vascular access in patients with out-of-hospital cardiac arrest (OHCA) remain controversial. This study compares the success rates of establis... This was a retrospective study conducted by the San-Min station of Taoyuan Fire Department. Data for IV access were collected between January 1, 2020, and December 31, 2020. Data for IO access were co... A total of 112 adult patients were enrolled in the analysis, including 71 men and 41 women, with an average age of 67 years. There were 90 IV access cases and 22 IO access cases. The groups were compa... The IO route was significantly associated with higher success rates of route establishment, epinephrine administration, and shorter time-to-epinephrine in the prehospital resuscitation of adult patien...

Male Humans Adult Female Aged +8 autres

Gonades : Questions médicales fréquentes

Termes MeSH sélectionnés :

Questions fréquentes et termes MeSH associés

Diagnostic 5

Symptômes 5

Prévention 5

Traitements 5

Complications 5

Facteurs de risque 5

Contenu validé par Dr Olivier Menir

Sous-catégories

Ovaire

Testicule

Corps jaune

Follicule ovarique

Auteurs principaux

Sources (10000 au total)